MedPath

Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds

Not Applicable
Completed
Conditions
Chronic Diabetic Foot Ulcers
Registration Number
NCT02098447
Lead Sponsor
Medical University of Vienna
Brief Summary

The purpose of this pilot study is to evaluate the effect of auricular autonomous nervous system stimulation on vital parameters of wound healing in diabetics. It is investigated if auricular vagal nerve stimulation has an effect on heart rate variability as well as peripheral local blood perfusion, and if this effect depends on the health status of the study participants (diseased/healthy).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • diabetes mellitus type 2
  • ulcus cruris (plantar)
  • min. 6 weeks of standard wound therapy without success
  • intact big toe on wound side
Exclusion Criteria
  • participation in a clinical trial in the last 5 weeks
  • confounding medical treatment, e.g. prostaglandin
  • vascular diseases other than peripheral arterial occlusive disease
  • diseases which may affect the autonomous nervous system or wound healing, except diabetic concomitant diseases (e.g., polyneuropathy, angiopathy)
  • drug abuse
  • active implanted devices
  • pregnancy or nursing

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
change in heart rate variability (HRV) related to physiological state (diabetics/healthy)within 4 days of intervention

Heart rate variability will be assessed as, e.g., standard deviation in heart rate over a time window of 5 minutes (30 seconds overlap).

Changes in mean value and standard deviation of heart rate variability between healthy and diabetic patients will be assessed using statistical tests.

change in local blood perfusion index (BPI) related to physiological state (diabetics/healthy)within 4 days of intervention

Blood perfusion index at the foot will be assessed as peak-peak amplitude (systolic to diastolic) divided by the mean signal value of optically measured blood perfusion.

Changes in mean value and standard deviation of local blood perfusion index between healthy and diabetic patients will be assessed using statistical tests.

Secondary Outcome Measures
NameTimeMethod
Perception of Stimulationwithin 4 days of intervention

Perception of stimulation is assessed by survey.

Change in HRV and local BPI due to distinct stimulation patternswithin 4 days of intervention

Two distinct stimulation patterns are tested during intervention.

Changes in mean value and standard deviation of HRV/BPI due to these stimulation patterns will be assessed using statistical tests.

Changes in respiratory activitywithin 4 days of intervention

Respiratory activity is monitored using a respiratory belt.

Changes in partial transcutaneous oxygen pressure of the wound regionwithin 4 days of intervention
Changes in oxygen saturation of the toe and woundwithin 4 days of intervention
Tolerance of stimulationwithin 4 days of intervention

Tolerance of stimulation is assessed by survey.

Changes in blood pressurewithin 4 days of intervention

Blood pressure is continuously measured using inflatable finger cuffs.

Change of local BPI in upper and lower extremitieswithin 4 days of intervention

Local BPI is assessed using optical sensors on the foot and the finger of participants.

Changes in mean value of BPI are analyzed using statistical tests.

Changes in foot skin temperaturewithin 4 days of intervention
Changes of C reactive protein- and leukocyte-concentration in serumwithin 4 days of intervention
Adverse effects of stimulationwithin 4 days of intervention

Trial Locations

Locations (1)

University Clinic for Surgery, Department of Transplantation, Medical University Vienna

🇦🇹

Vienna, Austria

University Clinic for Surgery, Department of Transplantation, Medical University Vienna
🇦🇹Vienna, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.